SEC Form 4 · accession 0000920465-15-000019
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis Mulroy
Officer — Chief Financial Officer
Period of report
Apr 6, 2015
Accepted (ET)
Apr 8, 2015 · 7:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $18.23 | Apr 6, 2015 | A | 60,000 | A | — | Apr 6, 2025 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1This option represents the right to purchase up to a total of 60,000 shares of the Issuer's common stock, par value $0.0001 per share (the "Option"). The Option will vest and become exercisable with respect to 25% of the underlying shares on the first anniversary of the date of grant, and then with respect to the remaining shares, on a monthly basis over the next three years, subject to the recipient's continued service during that time.